Hyperprogressive disease after radiotherapy combined with anti-PD-1 therapy in renal cell carcinoma: a case report and review of the literature

BACKGROUND: Studies have shown that immune checkpoint inhibitors (ICIs) have limited efficacy and can even increase tumour burden in short time periods. This is usually called hyperprogressive disease (HPD). To date, there are few reports regarding HPD; fewer have analysed the relationship between H...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chao, Piao, Jingjing, Shang, Zhiyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981866/
https://www.ncbi.nlm.nih.gov/pubmed/33743675
http://dx.doi.org/10.1186/s12894-021-00813-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7981866/
https://www.ncbi.nlm.nih.gov/pubmed/33743675
http://dx.doi.org/10.1186/s12894-021-00813-8

Ejemplares similares